Delivery Order SPE2DB22D2218-SPE2DB24FR2FJ
Award Date 3/22/24
Potential Completion Date 3/25/24
Potential Value $24K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,741.48 firm fixed-price delivery order is for the supply of LOTREL 10-20 MG CAPSULE 100S, a cardiovascular medication. The contract has an ultimate completion date of November 22, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $9,429.84, is a Firm Fixed Price Delivery Order contract for the supply of LOTREL 10-20 MG CAPSULE 100S, a cardiovascular medication. The contract has an ultimate completion date of July 3, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $20,494.59 Firm Fixed Price Delivery Order contract with the Defense Logistics Agency (DLA) to supply 4565286155 LOTREL 10-20 MG CAPSULE 100S. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025 between Amerisourcebergen and the DLA Troop Support Medical for delivering a comprehensive range of pharmaceutical and medical supplies to support...
- This federal contract award was granted to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $16,217.46 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical to supply the pharmaceutical product Lotrel 10-20 mg capsules. Amerisourcebergen Drug Corp has received numerous similar awards from DLA to provide a range of pharmaceutical products and medical supplies in support of military...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $12,896.27 Firm Fixed Price delivery order is for the supply of LOTREL 10-20 MG CAPSULE 100S, a cardiovascular medication. The contract has an ultimate completion date of December 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award, with ID SPE2DX15D3002|SPE2DX24F9PA9, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $10,254.53 firm fixed-price delivery order is for the pharmaceutical product Lotrel 10-20 mg capsules. The contract has an ultimate completion date of July 18, 2024 and is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,461.64, is for the delivery of 4562538247 LOTREL 10-20 MG CAPSULE 100S. The contract type is a Delivery Order with a Firm Fixed Price pricing structure and an ultimate completion date of October 20, 2023. The contract was awarded on October 19, 2023 and does not have a...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,890.68 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of 4,565,295,981 units of the drug Lotrel 10-20 mg capsules in 100-count packages. The contract has a period of performance through July 31, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal Bureau...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lotrel 10-20 mg capsules. The $31,616.33 firm fixed price contract has an ultimate completion date of August 22, 2024. This order is part of a larger indefinite delivery contract between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999, for delivering a comprehensive range of medical commodities to support...
- This federal contract award, valued at $24,980.73, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order under the DLA's Indefinite Delivery Contract (IDC) with Amerisourcebergen, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to supply a comprehensive range of pharmaceutical products and medical supplies, including...
- SPE2DB22D2218Indefinite Delivery Contract
- SPE2DB22D2218-SPE2DB24FR2FJDelivery Order
This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $23,811.70 firm fixed price delivery order is for the pharmaceutical product Lotrel 10-20 mg capsules, with a performance period through March 25, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary contract vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to military treatment programs and facilities worldwide. The contract does not have a set-aside designation.
Generated 6/21/24, 9:22 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.8k | 3/22/24 |